Adjuvant Chemotherapy for Superficial Transitional Cell Bladder Carcinoma: Long-term Results of a European Organization for Research and Treatment of Cancer Randomized Trial Comparing Doxorubicin, Ethoglucid and Transurethral Resection Alone-Reference-Cited by-同舟云学术

Adjuvant Chemotherapy for Superficial Transitional Cell Bladder Carcinoma: Long-term Results of a European Organization for Research and Treatment of Cancer Randomized Trial Comparing Doxorubicin, Ethoglucid and Transurethral Resection Alone

Published:1997-08 Issue:2 Volume:158 Page:378-384
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Kurth Karlheinz,Tunn Ulf,Ay Reginald,Schroder Fritz H.,Pavone-Macaluso Michele,Debruyne Frans,Ten Kate Fibo,De Pauw Marleen,Sylvester Richard

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference16 articles.

1. Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, hydrochloride, ethoglucid and transurethral resection alone;Kurth;J. Urol.,1984

2. Nonparametric estimation from incomplete observations.;Kaplan;J. Amer. Statis. Ass.,1958

3. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure.;Mantel;J. Amer. Statis. Ass.,1963

4. Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM-26) and TUR alone.;Schulman;Eur. Urol.,1982

5. The use of intravesical thiotepa in the management of non-invasive carcinoma of the bladder.;Koontz;J. Urol.,1981

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perfusion drugs for non‑muscle invasive bladder cancer (Review);Oncology Letters;2024-04-15

2. Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the Literature;PharmacoEconomics;2023-04-23

3. Selected protein expression in a new prognostic model for patients with non-muscle-invasive bladder cancer;Journal of Cancer Research and Clinical Oncology;2020-04-01

4. Effectiveness of Intravesical Doxorubicin Immediately Following Resection of Primary Non–muscle-invasive Bladder Cancer: A Propensity Score-matched Analysis;Clinical Genitourinary Cancer;2020-04

5. A rational risk assessment for intravesical recurrence in primary low‑grade Ta bladder cancer: A retrospective analysis of 245ï¿½cases;Molecular and Clinical Oncology;2018-04-02